Jetstream Capital’s InspireMD NSPR Stock Holding History

Jetstream Capital’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,000	Closed	-$83K	–	1
2024 Q1	$83K	Buy	+35,000	New	+$94.4K	3.6%	2

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return

Jetstream Capital's NSPR Position: Q2 2024 in Review

Jetstream Capital sold out of InspireMD (NSPR) in Q2 2024, closing a stake of 35,000 shares — an estimated $83K sold.

Jetstream Capital first reported a position in NSPR in Q1 2024 and held it in 1 quarter. The position peaked at $83K in Q1 2024. 24 funds tracked by Wall St. Rank hold NSPR as of Q2 2024.

Jetstream Capital reported no remaining InspireMD position as of Q2 2024 after selling out during the quarter.
Jetstream Capital sold 35,000 InspireMD shares in Q2 2024, an estimated $83K.
Jetstream Capital first reported a position in InspireMD in Q1 2024 and held it in 1 quarter.
Jetstream Capital's InspireMD position peaked at $83K in Q1 2024.
24 funds tracked by Wall St. Rank held InspireMD as of Q2 2024.

Based on Jetstream Capital's 13F filing for Q2 2024.